We’re moving! Datasets in the NIAGADS database are being transitioned to the DSS database, click to learn more.



National Institute on Aging (NIA)

The mission of NIA is to discover what may contribute to a healthy old age as well as to understand and address the disease and disability sometimes associated with growing older.

National Institutes of Health (NIH)

NIH’s mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability.

National Cell Repository for Alzheimer's Disease (NCRAD)

The goal of the National Cell Repository for Alzheimer’s Disease (NCRAD) is to help researchers find genes that increase the risk for Alzheimer’s disease (AD) and dementia.

National Alzheimer's Coordinating Center (NACC)

Using data collected from the 29 NIA-funded Alzheimer's Disease Centers (ADCs) across the United States, NACC has developed and maintains a large relational database of standardized clinical and neuropathological research data.

NIA Coordinating Center for the Genetics and Genomics of Alzheimer's Disease (CGAD)

The National Institute on Aging Coordinating Center for Genetics and Genomics of Alzheimer's Disease (CGAD) is funded under the NIA cooperative agreement award U54 AG052427 to identify genetic variants that cause, influence risk, or protect against this disorder, and to identify the underlying genes affected by these variants.

Alzheimer's Disease Genetics Consortium (ADGC)

The Alzheimer's Disease Genetics Consortium (ADGC) is funded by the National Institute on Aging (PI, Gerard D. Schellenberg; UO1AG032984) to conduct genome-wide association studies (GWAS) to identify genes
associated with an increased risk of developing late-onset Alzheimer’s disease (LOAD).

Global Alzheimer's Association Interactive Network (GAAIN)

The Global Alzheimer’s Association Interactive Network (GAAIN) is a big data community for cohort discovery and data exploration that promotes data sharing among a federated, global network of data partners who are studying Alzheimer’s disease and other dementias. It is a collaborative project that provides researchers around the globe access to clinical, genetic, and imaging data on Alzheimer’s disease from hundreds of thousands of subject participants through compelling and intuitive graphical user interfaces. Led by Dr. Arthur Toga, Director of the Laboratory of Neuro Imaging (LONI) at the University of Southern California, GAAIN’s goal is to transform the way researchers work together to answer fundamental questions related to understanding the causes, diagnosis, treatment, and prevention of Alzheimer’s disease. To learn more and use GAAIN, visit http://www.gaain.org.

University of Pennsylvania

The University of Pennsylvania is a private, Ivy League university located in Philadelphia.

Perelman School of Medicine

The mission of the Perelman School of Medicine is to advance knowledge and improve health through research, patient care, and the education of trainees in an inclusive culture that embraces diversity, fosters innovation, stimulates critical thinking, supports lifelong learning, and sustains our legacy of excellence.

Department of Pathology and Laboratory Medicine

The Department of Pathology and Laboratory Medicine at Penn traces its origins to 1895 when the William Pepper Laboratory of Clinical Medicine, the nation’s first fully equipped laboratory for routine and investigative work, was founded with the purpose “to promote the interests of the patients in the … University Hospital by the prosecution of minute clinical studies and original researches.”

Wang Lab

The Wang Lab at the University of Pennsylvania focuses on the genetics and genomics of Alzheimer’s disease and other neurodegenerative disorders, and informatics and algorithm development for genome-scale experiments.

Penn Neurodegeneration Genomics Center (PNGC)

PNGC studies genetics of Alzheimer’s Disease and other related dementia. Our researchers apply high throughput genotyping and sequencing technologies to analyze tens of thousands of genomes and find novel genes.  New experimental approaches, algorithms, and databases are developed in order to translate these findings into biological knowledge about the disease and new directions for drug discovery and preventive strategies.

Institute for Biomedical Informatics (IBI)

The mission of IBI is to provide an interdisciplinary home for faculty, staff and students interested in bioinformatics, clinical informatics, clinical research informatics, consumer health informatics, and public health informatics. It is our goal to improve healthcare and fundamental knowledge of biological systems by creating an informatics ecosystem through cutting-edge educational programs, computational infrastructure, and collaborative research.



Useful Links